This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

LIFE study

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • revealed that treatment with losartan reduced the incidence of stroke by 25% compared to atenolol therapy in the four year study
  • LIFE study was a double-masked, randomised, parallel-group trial in more than 9000 patients with essential hypertension and electrocardiographic evidence of left ventricular hypertrophy
    • patients were assigned to once-daily losartan (n=4605) or once daily atenolol (n=4588) (both therapies at maximum doses of 100mg), to which diuretics and other antihypertensive drugs - with the exception of ACE inhibitors, or other angiotensin II antagonists or beta blockers - could be added, as required, to normalise BP
    • the trial was designed to last for at least four years and until 1040 patients had a primary cardiovascular event (death, MI or stroke)
    • there was a significant difference in the incidence of stroke with losartan (5%) and atenolol (7%) therapies (p=0.001); the rates of cardiovascular mortality and MI were not significantly different between the groups - however, note that the effect of losartan being the same as that of atenolol is important because it is known that atenolol therapy reduces the risk of MI by 30% in this patient population
    • in the diabetes subgroup (1195 patients, 586 treated with losartan), there was a 24% reduction in risk of the primary end point in the losartan group (p=0.031) and a 39% reduction in all-cause mortality (p=0.002)
    • the onset of diabetes was 25% less in the losartan arm
    • losartan and atenolol had similar BP-lowering effects
  1. Lancet (2002), 359:995-1003.

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.